ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

NIH Seeks Candidates For Research Grants Division Director

September 8, 1995

CCOPs, Research Base Awards Are Listed

November 19, 1993

NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive

March 23, 1984

NCI awards $42 million for prevention trials consortium.

December 5, 2003

Electric Blankets May Be Risk Factor In Childhood Cancer

May 18, 1990

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

April 13, 2012